Dina M. Seoudi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dina M. Seoudi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Emad Fawzi Eskander
Hormones Department, Medical Research Division, National Research Centre, Cairo, Egypt
4 shared publications - Hanaa Hamdy Ahmed
Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt
4 shared publications - Abdel-Rahman Badr Abdel-Ghaffar
Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
2 shared publications - Amina Mohammed Medhat
Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
2 shared publications Awatif M. Abd El-Maksoud
Clinical Nutrition Department, National Nutrition Institute, Cairo, Egypt
2 shared publications- Aziza Bakr Shalby
National Research Centre
2 shared publications
Latest Publications
- 1 October 2012
- Vol. 16 (10) , 1446-52
Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats.
The present study assessed the potential role of leptin administration in the protection and intervention against glucocorticoid-induced secondary osteoporosis in female rats. For this purpose five groups of female Sprague Dawley rats were classified into: (1) negative control group in which the healthy rats received saline as vehicle, (2) a group orally administered with prednisolone (5 mg kg b.wt.-1) daily for six months (osteoporotic group), (3) a group subcutaneously administered with leptin (400 microg kg b.wt.-1) three times weekly for six months (positive control), (4) a group orally administered with prednisolone daily with simultaneous subcutaneous administration of leptin three times weekly for six months (protective group), and (5) a group orally administered with prednisolone daily for six months then subcutaneously administered with leptin three times weekly for other six months (therapeutic group). The obtained data revealed that prednisolone administration resulted in significant decrease in serum osteoprotegerin (OPG) level accompanied with significant increase in serum receptor activator of nuclear factor-κB ligand (RANKL) and beta2-microglobulin levels in comparison with the negative control group. Moreover, prednisolone significantly decreased bone mineral density and content of different areas of the right femur bones as compared to the negative control group. Furthermore, administration of leptin with/after stopping prednisolone administration resulted in a marked modulation in the majority of bone biomarkers as well as improvement in bone mineral density and content. Leptin provided promising effect on bone through its direct action on bone and matrix mineralization.
- 1 October 2012
- Vol. 16 (10) , 1446-52
Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats.
The present study assessed the potential role of leptin administration in the protection and intervention against glucocorticoid-induced secondary osteoporosis in female rats. For this purpose five groups of female Sprague Dawley rats were classified into: (1) negative control group in which the healthy rats received saline as vehicle, (2) a group orally administered with prednisolone (5 mg kg b.wt.-1) daily for six months (osteoporotic group), (3) a group subcutaneously administered with leptin (400 microg kg b.wt.-1) three times weekly for six months (positive control), (4) a group orally administered with prednisolone daily with simultaneous subcutaneous administration of leptin three times weekly for six months (protective group), and (5) a group orally administered with prednisolone daily for six months then subcutaneously administered with leptin three times weekly for other six months (therapeutic group). The obtained data revealed that prednisolone administration resulted in significant decrease in serum osteoprotegerin (OPG) level accompanied with significant increase in serum receptor activator of nuclear factor-κB ligand (RANKL) and beta2-microglobulin levels in comparison with the negative control group. Moreover, prednisolone significantly decreased bone mineral density and content of different areas of the right femur bones as compared to the negative control group. Furthermore, administration of leptin with/after stopping prednisolone administration resulted in a marked modulation in the majority of bone biomarkers as well as improvement in bone mineral density and content. Leptin provided promising effect on bone through its direct action on bone and matrix mineralization.
- 1 September 2012
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 64 (6) , 659-664
Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats
- 1 September 2012
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 64 (6) , 659-664
Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats
- 1 November 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 389 (2) , 211-216
Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: Evidence for PKC activation and oxidative stress-activated signaling pathways
- 1 November 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 389 (2) , 211-216
Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: Evidence for PKC activation and oxidative stress-activated signaling pathways
- 30 September 2009
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (13-14) , 1401-1406
Early predictors of microvascular complications in type 1 diabetic patients
- 30 September 2009
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (13-14) , 1401-1406
Early predictors of microvascular complications in type 1 diabetic patients
- 1 August 2009
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 3 (4) , 269-274
Adiponectin, leptin, and lipid profile in type 1 diabetic children and adolescents
- 1 August 2009
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 3 (4) , 269-274
Adiponectin, leptin, and lipid profile in type 1 diabetic children and adolescents